AstraZeneca (AZN) has released an update.
AstraZeneca PLC, the science-led biopharmaceutical company, has announced that as of March 31, 2024, their total issued share capital with voting rights stands at 1,550,221,288 ordinary shares. This figure is crucial for shareholders to calculate notifications of interest changes according to the UK’s Financial Conduct Authority rules. The company, known for its prescription medicines in various therapeutic areas, operates globally and is headquartered in Cambridge, UK.
For further insights into AZN stock, check out TipRanks’ Stock Analysis page.
